insights_auto
Why is DFTX up 2.31%?
Dive Deeperchevron_right
DFTX:NASDAQ
Definium Therapeutics Inc
$32.84
arrow_upward
+2.31%(+0.74) 1D
Oct 19, 10:44:17 AM GMT-4 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for DFTX...
Open
$32.28
High
$33.24
Low
$32.23
Mkt. cap
4.41B
Avg. vol.
2.32M
Volume
227.74K
52-wk high
$49.70
52-wk low
$14.62
EPS
-$3.43
Beta
2.19
Shares outstanding
134.37M
No. of employees
106
Open
$32.28
High
$33.24
Low
$32.23
Mkt. cap
4.41B
Avg. vol.
2.32M
Volume
227.74K
52-wk high
$49.70
52-wk low
$14.62
EPS
-$3.43
Beta
2.19
Shares outstanding
134.37M
No. of employees
106
News stories
From web sources and news partners
Investing.com UK
·
25 minutes ago
RBC Capital reiterates Definium Therapeutics stock rating on strong trial data
Stock Traders Daily
·
1 day ago
(DFTX) Risk Channels and Responsive Allocation
Profile
Definium Therapeutics, Inc., formerly known as MindMed, is a New York-based biotechnology company that is currently developing clinical and therapeutic applications for psychedelic and, more broadly, psychoplastogenic drugs. Wikipedia
About Definium Therapeutics Inc
CEORobert Barrow
Employees106
Founded2010
Headquarters-
SectorPharmaceutical industry
Websitedefiniumtx.com